Cargando…
Commentary: Euthyroid Sick Syndrome in Patients With COVID-19
Autores principales: | Laurino, Annunziatina, Gencarelli, Manuela, Buci, Lisa, Raimondi, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928301/ https://www.ncbi.nlm.nih.gov/pubmed/33688850 http://dx.doi.org/10.3389/fendo.2021.633097 |
Ejemplares similares
-
Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
por: Laurino, Annunziatina, et al.
Publicado: (2018) -
Commentary: Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut—From Gut to Brain?
por: Laurino, Annunziatina, et al.
Publicado: (2017) -
Euthyroid Sick Syndrome in Patients With COVID-19
por: Zou, Runmei, et al.
Publicado: (2020) -
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases
por: Laurino, Annunziatina, et al.
Publicado: (2018) -
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue
por: Landucci, Elisa, et al.
Publicado: (2019)